EIT Health
Government organization
Active
Munich, Germany
93
759K
79
10.33
39
0.14
1
- Areas of investment
Summary
The company was established in Europe in Germany. The leading representative office of defined Corporate Investor is situated in the Munich.
The usual cause for the fund is to invest in rounds with 1-2 partakers. Despite the EIT Health, startups are often financed by Venture Kick, MassChallenge, Horizon 2020. The meaningful sponsors for the fund in investment in the same round are Torret Road Capital, Techstars, Nina Capital. In the next rounds fund is usually obtained by Horizon 2020, EASME - EU Executive Agency for SMEs, SBRI Healthcare.
Besides, a startup needs to be aged 2-3 years to get the investment from the fund. Among the various public portfolio startups of the fund, we may underline AVX Pharma, GlyCardial Diagnostics, Inovus Medical The fund has no exact preference in some founders of portfolio startups. In case when startup counts 5+ of the founder, the chance for it to get the investment is meager. Among the most popular fund investment industries, there are Life Science, Medical. For fund there is no match between the country of its foundation and the country of its the most frequent investments - Spain.
The usual things for fund are deals in the range of 100 thousands - 1 million dollars. The fund is generally included in 7-12 deals every year. Speaking about the real fund results, this Corporate Investor is 12 percentage points more often commits exit comparing to other organizations. The increased amount of exits for fund were in 2019. The important activity for fund was in 2018. When the investment is from EIT Health the average startup value is 1-5 millions dollars.
Investor highlights
- Stage focus
Discover reliable insights
Find relevant VC investors, identify key contacts and secure funding opportunities.
Investments analytics
Analytics
- Total investments
- 93
- Lead investments
- 39
- Exits
- 1
- Rounds per year
- 10.33
- Follow on index
- 0.14
- Investments by industry
- Health Care (66)
- Medical Device (42)
- Medical (34)
- Biotechnology (24)
- Artificial Intelligence (18) Show 62 more
- Investments by region
-
- United Kingdom (17)
- France (1)
- Switzerland (11)
- Netherlands (4)
- Spain (17) Show 14 more
- Peak activity year
- 2020
Discover reliable insights
Leverage validated data, identify key contacts and secure funding opportunities for your business.Quantitative data
- Avg. startup age at the time of investment
- 6
- Avg. valuation at time of investment
- 397K
- Group Appearance index
- 0.15
- Avg. company exit year
- 6
Need more data?
Get access to full data about investors, including their team, contact information, and historic data.
Latest deals
Company name | Deal date | Industry | Deal stage | Deal size | Location |
---|---|---|---|---|---|
KroniKar.ai | 02 Jun 2020 | Biotechnology, Software, Artificial Intelligence, Health Care, Medical | Seed | 59K | Central, Singapore, Singapore |
NovaBleep | 30 Mar 2021 | Analytics, Information Technology, Artificial Intelligence, Machine Learning, Health Care, Hospital, Big Data, Medical, Communications Infrastructure, Data Visualization | Seed | 205K | |
Book. Stay. Go. | 16 Sep 2015 | Mobile, SaaS, Marketplace, Hospitality | Seed | 1M | United States, California, San Francisco |
At Unicorn Nest, we combine cutting-edge technology with human expertise to build one of the most reliable venture capital databases in the market. Our process begins with automated AI-enhanced data collection, leveraging the full potential of Large Language Models (LLMs).
Later, our team of analysts takes it further with manual verification, using proprietary tools for data cleaning and validation to ensure accuracy and reliability. We cross-check and enhance our findings through press and media monitoring, integrating information from trusted news outlets and venture capital aggregators. Finally, we stay ahead of the curve by monitoring social networks like LinkedIn and X.com.